Equities

TheraCryf PLC

TCF:LSE

TheraCryf PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.85
  • Today's Change0.00 / 0.00%
  • Shares traded12.39k
  • 1 Year change-72.13%
  • Beta1.5751
Data delayed at least 20 minutes, as of Jul 05 2024 10:56 BST.
More ▼

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2024, cash reserves at TheraCryf PLC fell by 3.00m. However, Cash Flow from Investing was flat, indicating that little new money was committed to growth. In addition the company used 3.00m for operations while cash used for financing totalled .
Cash flow per share-0.0114
Price/Cash flow per share--
Book value per share0.0085
Tangible book value per share0.0084
More ▼

Balance sheet in GBPView more

TheraCryf PLC appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio4.19
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.